NCT02356445Unknown不适用
Outcome of Use of Cytotoxic Drugs for Inflammatory Lung Diseases
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 2,000
- 试验地点
- 1
- 主要终点
- Clinical Outcome
研究概览
简要总结
Retrospective review of the outcome of use of immunosuppressive drugs in treatment of sarcoidosis
详细描述
Patients receiving one or more cytotoxic or other immunosuppressive drug will be observed
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 15 Years 至 90 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Any patient treated for sarcoidosis
排除标准
- 未提供
结局指标
主要结局
Clinical Outcome
时间窗: 2 years
Number of participants with improvement over two years
次要结局
- Toxicity(2 years)
研究者
Robert P Baughman
Professor of Medicine
University of Cincinnati
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Investigation of the Efficacy of Antibiotics on Pulmonary SarcoidosisPulmonary SarcoidosisLung FunctionNCT01169038Vanderbilt University15
进行中（未招募）
3 期
Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in SarcoidosisSarcoidosisNCT05689879Assistance Publique - Hôpitaux de Paris32
已完成
3 期
Efficacy and Safety of Influenza Vaccine During SarcoidosisInfluenza VaccineSarcoidosisNCT01687517Assistance Publique - Hôpitaux de Paris190
已完成
不适用
A Study to Evaluate the Efficacy and Safety of Fenestrated Cup Forceps Versus Fenestrated Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With SarcoidosisSarcoidosisNCT02405897Post Graduate Institute of Medical Education and Research, Chandigarh150
招募中
4 期
RCT of Nintedanib in Fibrotic SarcoidosisSarcoidosis, PulmonaryNCT06479603Post Graduate Institute of Medical Education and Research, Chandigarh120